Video

Findings help investigators understand how FDA-approved AGN-19058 behaves

Author(s):

Kassi Jackson
Conferences|ASCRS

George Waring, MD, discusses the findings of a retrospective study on Allergan’s AGN-190584 for the treatment of presbyopia.

Related Videos
Image credit: ©Ophthalmology Times
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Related Content
HelpMeSee announces new training partnerships, simulation training sites
January 21st 2025

HelpMeSee announces new training partnerships, simulation training sites

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma
January 9th 2025

Sight Sciences announces publication of 36-month analysis of OMNI Surgical System in managing primary open-angle glaucoma

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Enhancing precision in GA imaging
December 12th 2024

Enhancing precision in GA imaging

Study: Fluoxetine improves visual acuity in adults with amblyopia
December 11th 2024

Study: Fluoxetine improves visual acuity in adults with amblyopia

© 2025 MJH Life Sciences

All rights reserved.